| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2003;75:1720-1726
© 2003 The Society of Thoracic Surgeons
a Service de Chirurgie Digestive et Générale Hôpital Claude Huriez, Lille Cedex, France,
b Unité INSERM 560–CHRU, Lille, France
Accepted for publication January 14, 2003.
* Address reprint requests to Dr Triboulet, Service de Chirurgie Digestive et Générale Hôpital, Claude Huriez–CHRU, Place de Verdun, Lille Cedex 59037, France
e-mail: jp-triboulet{at}chru-lille.fr
BACKGROUND: Esophagectomy remains a standard treatment for patients with resectable esophageal cancer, but the 5-year survival is only 20% to 25%. After complete resection survival is significantly longer than after incomplete resection with microscopic or macroscopic penetration. The purpose of this study was to prospectively identify the factors predictive of complete resection of operable esophageal cancers.
METHODS: Betwen January 1995 and January 2002, 372 patients with esophageal cancer underwent surgery with curative intent. Complete resection was performed in 304 patients (81.7%), incomplete resection with microscopic penetration in 28 (7.5%), and incomplete resection with macroscopic penetration in 40 (10.8%). Univariate and multivariate analysis included 16 preoperative and operative factors.
RESULTS: Factors predictive of complete resection were absence of any modification of the esophageal axis on the barium swallow (p = 0.019) and a partial or complete response to preoperative radiochemotherapy (p = 0.042). Three groups of patients were identified: group 1 had no deviation of the axis on the barium swallow (n = 253); group 2 had deviation of the axis on the barium swallow and partial or complete response to radiochemotherapy (n = 66); and group 3 had deviation of the axis on the barium swallow and no response to radiochemotherapy or no preoperative treatment (n = 53). Rates of complete resection were 90.1%, 74.2%, and 50.9%, and 5-year actuarial survivals were 46%, 37%, and 0%, respectively (p < 0.001).
CONCLUSIONS: Complete resection of esophageal cancer is predictable. Deviation axis on the barium swallow and morphologic response to neoadjuvant radiochemotherapy are variables available for all patients at onset of therapeutic management.
This article has been cited by other articles:
|
|
 |
|
  J. W. Fletcher, B. Djulbegovic, H. P. Soares, B. A. Siegel, V. J. Lowe, G. H. Lyman, R. E. Coleman, R. Wahl, J. C. Paschold, N. Avril, et al. Recommendations on the Use of 18F-FDG PET in Oncology J. Nucl. Med., March 1, 2008; 49(3): 480 - 508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Piessen, N. Briez, J.-P. Triboulet, and C. Mariette Patients with Locally Advanced Esophageal Carcinoma Nonresponder to Radiochemotherapy: Who Will Benefit From Surgery? Ann. Surg. Oncol., July 1, 2007; 14(7): 2036 - 2044. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Berger, J. Farma, W. J. Scott, G. Freedman, L. Weiner, J. D. Cheng, H. Wang, and M. Goldberg Complete Response to Neoadjuvant Chemoradiotherapy in Esophageal Carcinoma Is Associated With Significantly Improved Survival J. Clin. Oncol., July 1, 2005; 23(19): 4330 - 4337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Mariette, G. Taillier, I. Van Seuningen, and J.-P. Triboulet Factors Affecting Postoperative Course and Survival After En Bloc Resection for Esophageal Carcinoma Ann. Thorac. Surg., October 1, 2004; 78(4): 1177 - 1183. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
